186 related articles for article (PubMed ID: 33232304)
1. Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity.
Moreira D; Sampath S; Won H; White SV; Su YL; Alcantara M; Wang C; Lee P; Maghami E; Massarelli E; Kortylewski M
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33232304
[TBL] [Abstract][Full Text] [Related]
2. CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.
Agresta L; Lehn M; Lampe K; Cantrell R; Hennies C; Szabo S; Wise-Draper T; Conforti L; Hoebe K; Janssen EM
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217758
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy.
Hanoteau A; Newton JM; Krupar R; Huang C; Liu HC; Gaspero A; Gartrell RD; Saenger YM; Hart TD; Santegoets SJ; Laoui D; Spanos C; Parikh F; Jayaraman P; Zhang B; Van der Burg SH; Van Ginderachter JA; Melief CJM; Sikora AG
J Immunother Cancer; 2019 Jan; 7(1):10. PubMed ID: 30646957
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
[TBL] [Abstract][Full Text] [Related]
5. Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy.
Alcantara MB; Tang WS; Wang D; Kaniowski D; Kang E; Dizman N; Chehrazi-Raffle A; Meza L; Zengin Z; Hall J; Hsu J; Egelston C; Moreira D; Horsager A; Pal SK; Kortylewski M
Front Immunol; 2023; 14():1274781. PubMed ID: 38259453
[TBL] [Abstract][Full Text] [Related]
6. The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy.
Starska-Kowarska K
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980527
[TBL] [Abstract][Full Text] [Related]
7.
Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
[TBL] [Abstract][Full Text] [Related]
8. Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer.
Kono M; Saito S; Rokugo M; Egloff AM; Uppaluri R
Oral Oncol; 2024 May; 152():106795. PubMed ID: 38599127
[TBL] [Abstract][Full Text] [Related]
9. Immune Suppression Mediated by STAT4 Deficiency Promotes Lymphatic Metastasis in HNSCC.
Anderson K; Ryan N; Volpedo G; Varikuti S; Satoskar AR; Oghumu S
Front Immunol; 2019; 10():3095. PubMed ID: 32010142
[TBL] [Abstract][Full Text] [Related]
10. IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models.
Yu J; Gadwa J; Ross RB; Knitz M; Darragh LB; Abdelazeem KNM; Beynor J; Neupert B; Nguyen A; Nguyen D; Olimpo N; Corbo S; Van Court B; D'Alessandro A; Saviola A; Karam SD
Cancer Immunol Immunother; 2024 Mar; 73(5):90. PubMed ID: 38554147
[TBL] [Abstract][Full Text] [Related]
11. Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs.
Darragh LB; Nguyen A; Pham TT; Idlett-Ali S; Knitz MW; Gadwa J; Bukkapatnam S; Corbo S; Olimpo NA; Nguyen D; Van Court B; Neupert B; Yu J; Ross RB; Corbisiero M; Abdelazeem KNM; Maroney SP; Galindo DC; Mukdad L; Saviola A; Joshi M; White R; Alhiyari Y; Samedi V; Van Bokhoven A; St John M; Karam SD
Med; 2024 Mar; 5(3):254-270.e8. PubMed ID: 38423011
[TBL] [Abstract][Full Text] [Related]
12. A Macrophages-Enriched Head and Neck Tumor Spheroid Model to Study Foslip
Francois A; Dirheimer L; Chateau A; Lassalle HP; Yakavets I; Bezdetnaya L
Int J Nanomedicine; 2023; 18():6545-6562. PubMed ID: 37965282
[TBL] [Abstract][Full Text] [Related]
13. Establishment of an in situ model to explore the tumor immune microenvironment in head and neck squamous cell carcinoma.
Lu C; Yang Y; Zhang M; Li J; Song H; Zhao H; Mou Y; Li Y; Song X
Head Neck; 2024 Jun; 46(6):1310-1321. PubMed ID: 38436502
[TBL] [Abstract][Full Text] [Related]
14. CHMP2A regulates broad immune cell-mediated antitumor activity in an immunocompetent in vivo head and neck squamous cell carcinoma model.
Yun J; Saddawi-Konefka R; Goldenson B; Al-Msari R; Bernareggi D; Thangaraj JL; Tang S; Patel SH; Luna SM; Gutkind JS; Kaufman D
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38702144
[TBL] [Abstract][Full Text] [Related]
15. Momordicine-I Suppresses Head and Neck Cancer Growth by Reprogrammimg Immunosuppressive Effect of the Tumor-Infiltrating Macrophages and B Lymphocytes.
Sur S; Bhartiya P; Steele R; Brennan M; DiPaolo RJ; Ray RB
Mol Cancer Ther; 2024 May; 23(5):672-682. PubMed ID: 38315993
[TBL] [Abstract][Full Text] [Related]
16. HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer.
Chen F; Tang C; Yang F; Ekpenyong A; Qin R; Xie J; Momen-Heravi F; Saba NF; Teng Y
Sci Adv; 2024 Feb; 10(8):eadk3663. PubMed ID: 38394204
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma.
Lechner A; Schlößer HA; Thelen M; Wennhold K; Rothschild SI; Gilles R; Quaas A; Siefer OG; Huebbers CU; Cukuroglu E; Göke J; Hillmer A; Gathof B; Meyer MF; Klussmann JP; Shimabukuro-Vornhagen A; Theurich S; Beutner D; von Bergwelt-Baildon M
Oncoimmunology; 2019; 8(3):1535293. PubMed ID: 30723574
[TBL] [Abstract][Full Text] [Related]
18. Construction of CpG Delivery Nanoplatforms by Functionalized MoS
Li H; Liu M; Zhang S; Xie X; Zhu Y; Liu T; Li J; Tu Z; Wen W
Small; 2023 Oct; 19(41):e2300380. PubMed ID: 37340576
[TBL] [Abstract][Full Text] [Related]
19. Stroma modulation of radiation response in head and neck squamous cell carcinoma: Insights from zebrafish larvae xenografts.
Wahbi W; Awad S; Salo T; Al-Samadi A
Exp Cell Res; 2024 Feb; 435(1):113911. PubMed ID: 38182078
[TBL] [Abstract][Full Text] [Related]
20. Autologous reconstitution of human cancer and immune system in vivo.
Fu J; Sen R; Masica DL; Karchin R; Pardoll D; Walter V; Hayes DN; Chung CH; Kim YJ
Oncotarget; 2017 Jan; 8(2):2053-2068. PubMed ID: 28008146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
